Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution.
COVID-19
delays of surgery
thoracic surgery
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
26
01
2022
accepted:
30
05
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
9
9
2022
Statut:
ppublish
Résumé
The impact of COVID-19 has been felt in every field of medicine. We sought to understand how lung cancer surgery was affected at a high volume institution. We hypothesized that patients would wait longer for surgery, have more advanced tumors, and experience more complications during the COVID-19 crisis. A retrospective review was conducted, comparing pathologically confirmed non-small cell lung cancer (NSCLC) surgical cases performed in 2019 to cases performed from March to May 2020, during the height of the COVID-19 crisis. Clinical and pathologic stage, tumor size, time to surgery, follow up time, and complications were evaluated. A total of 375 cases were performed in 2019 Surgical wait time, pathologic tumor size, and complications were not different among patients undergoing surgery before
Sections du résumé
Background
UNASSIGNED
The impact of COVID-19 has been felt in every field of medicine. We sought to understand how lung cancer surgery was affected at a high volume institution. We hypothesized that patients would wait longer for surgery, have more advanced tumors, and experience more complications during the COVID-19 crisis.
Methods
UNASSIGNED
A retrospective review was conducted, comparing pathologically confirmed non-small cell lung cancer (NSCLC) surgical cases performed in 2019 to cases performed from March to May 2020, during the height of the COVID-19 crisis. Clinical and pathologic stage, tumor size, time to surgery, follow up time, and complications were evaluated.
Results
UNASSIGNED
A total of 375 cases were performed in 2019
Conclusions
UNASSIGNED
Surgical wait time, pathologic tumor size, and complications were not different among patients undergoing surgery before
Identifiants
pubmed: 36071771
doi: 10.21037/jtd-22-5
pii: jtd-14-08-2874
pmc: PMC9442535
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2874-2879Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
2022 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-5/coif). SJS is a consultant for Ethicon and Covidien. The other authors have no conflicts of interest to declare.
Références
J Thorac Oncol. 2017 Feb;12(2):314-322
pubmed: 27720827
Ann Thorac Surg. 2015 Jun;99(6):1906-12; discussion 1913
pubmed: 25890663
Cancers (Basel). 2021 Jun 09;13(12):
pubmed: 34207878
Eur J Cardiothorac Surg. 2020 Oct 1;58(4):752-762
pubmed: 32862224
J Thorac Oncol. 2020 Jul;15(7):1119-1136
pubmed: 32422364
JAMA Oncol. 2021 Mar 1;7(3):458-460
pubmed: 33443549
J Am Coll Surg. 2021 Apr;232(4):600-605
pubmed: 33346080
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):466-72
pubmed: 20471184